Metraipolis › archive › dc_7924cc815ebf

Repurposing Antiretroviral Drugs for Urological Cancers: Differential Effects of Protease Inhibitors and NNRTIs on Prostate and Bladder Cancer Cells — Europe PMC PMID:42346075

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346075
DOI
10.3390/cells15121045
License (as archived)
solo-consultazione
Archived
2026-10-31T17:18:01.400Z
SHA-256 of the archived text
a33c2aa175a210a725aa830f5662f81ab2c982245ad2f3e08f9e3a751553ea0d
Stable URL of this page
https://metraipolis.com/documento/dc_7924cc815ebf

How to cite

Repurposing Antiretroviral Drugs for Urological Cancers: Differential Effects of Protease Inhibitors and NNRTIs on Prostate and Bladder Cancer Cells — Europe PMC PMID:42346075 — Europe PMC (en), https://europepmc.org/article/MED/42346075 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7924cc815ebf (Metraipolis archive dc_7924cc815ebf, sha256 a33c2aa175a210a725aa830f5662f81ab2c982245ad2f3e08f9e3a751553ea0d)
BibTeX
@misc{dc7924cc815ebf,
  title = {Repurposing Antiretroviral Drugs for Urological Cancers: Differential Effects of Protease Inhibitors and NNRTIs on Prostate and Bladder Cancer Cells — Europe PMC PMID:42346075},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346075},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7924cc815ebf; sha256 a33c2aa175a210a725aa830f5662f81ab2c982245ad2f3e08f9e3a751553ea0d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346075. Agents can read the archived copy with the MCP tool read_document.